Artificial Disc Replacement Market to Register Substantial Expansion by 2025



Spinal discs act as cushions or shock absorbers for the vertebrae and are located between the bones or vertebrae of the spine. These discs are instrumental in rendering flexibility and movement of the spinal column. There are two major parts of discs namely, inner and outer portion. Inner portion comprises a jelly like material while stronger and fibrous material constitutes the outer portion of the discs. Due to aging, these discs are subjected to tear or crack in the outer portion resulting in degenerative disc disorders along with other complications such as bulging out in the inner portion of the disc resulting in pressure on the outer portion that leads to pain.

Artificial disc replacement procedure is performed to replace the worn out tissues while retaining the motion and functionality of the spine. This results in reduced back pain and low risk for development of an adjacent level of spine which is the degeneration of segments above or below the implant. An artificial disc, a prosthetic device is inserted between the vertebrae and results in replacement of natural and defective spinal disc. In cases of failure of non-surgical procedures, the doctors recommend spinal fusion surgery (traditional procedure) for treating disc degenerative disorders.


Spinal fusion surgery involved the use of bone grafts along with screws and metal plates and results in fusion of two adjacent vertebrae resulting in stabilization of spine segment and reduces the back pain. However, it results in lack of movement and flexibility in the vertebral segment. Artificial disc replacement or arthroplasty is advantageous over the conventional surgical procedures as it retains the mobility within the disc space and throughout the vertebral segment.

There are two major types of artificial discs such as nuclear prosthesis (designed to replace inner core of a disc) and total disc prosthesis (designed to replace full disc). These discs are composed of man-made materials such as metal part of the disc and rubber polyethylene for the inner core. Artificial disc replacement is recommended in the following conditions:

In the U.S., the clinical trials for the use of artificial discs and the approval by Food and Drug Administration (FDA) require around 5 years. However owing to earlier approvals and differences in the regulatory scenario, the rate of usage and adoption of artificial discs in European countries is considerably higher as compared to the United States. The market for artificial disc replacement can be analyzed on the basis of the indications for which the replacement procedure is recommended and also analyzed by a regional distribution of the market by four major geographies namely Europe, North America, Asia-Pacific and RoW.


The major factors favoring the growth of the market are consistent technological sophistications and increased benefits of artificial discs over the conventional spinal fusion procedures. In addition, the increasing number of patients suffering from disc degenerative disorders and increased affordability of the patients further fuel the growth of the market.

On the other hand, unfavorable reimbursement scenario along with the risks associated with replacement procedures and lack of expertise in performing the procedure might hamper the growth of the market. Furthermore, high costs involved in R&D along with high procedure costs might negatively impact the growth of the market. Cervical disc Actif C (by Aesculap) is cervical disc prosthesis used to treat degenerative cervical disc disease and Alphate (Cervical disc Discovery), Cervical Disc Altia (by Amedica Corporation) and Discover (by Depuy-Synthes) are some of the artificial discs available in the market.

Comments

Post a Comment

Popular posts from this blog

Head Guards Market is Expected to Witness a Steady Growth by 2028

Market Overview Safety equipment plays an important role in protecting sports enthusiasts from various injuries. Head guard is the key protection equipment widely used in games like boxing, baseball and rugby. This equipment has gained traction among athletes from amateur to professional players in both, national and international competitions. Rising number of national and international sports competitions globally, the demand for head guards has surged, which will in turn increase the volume of head guard sells from retail outlets to the company online sales channel. Many sports associations such as World Rugby, International Baseball Federation and World Boxing Association have necessitated the use of head guards for players in sports matches. In baseball alone, there are over 35 million players at different levels, and the U.S. houses close to 14 million amateur and professional players. This massive number of participants in baseball creates a significant customer base for h...
Read more

Die Cut Box Market to Witness an Outstanding Growth by 2028

Die Cut Box Marke t: Overview Die cut box is an innovative packaging solution for multiple end-use sectors. Growing need for fast moving consumer goods, ingenious packaging formats from design, and size perspective,  die cut box continues to offer an advantageous edge in product positioning. Die cut box allows the leading brands and manufacturers to integrate novel design elements, which in turn assures a higher threshold of customer acquisition viz.a.viz. effective branding and marketing. Besides industry specific drivers and trends, macroeconomic factors will also continue to influence demand for the die cut box across industries. Such factor include but aren’t limited to per capita disposable income, food retail sector growth, modern retail establishment growth etc. Outpacing growth in the e-commerce sector has gained traction for the corrugated packaging industry. Die cut box cost wouldn’t be a big burn to the pocket of die cut box manufacturers despite the re-usability of ...
Read more

Gynaecological Cancer Drugs Market Accounting US$ 41,855.8 million by 2026

The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026. Treatment of cancer is being increasingly focused on be leading pharmaceutical companies, researchers, healthcare institutes and governments of various countries. With increasing number of research and development activities in cancer treatment, especially in gynaecological cancer treatment, new treatments are reaching an increasing number of physicians faster than ever. Also, availability of advanced treatment options and drugs has resulted in the decline in cancer mortality rate across major developed countries. However, the scenario is not same in the developing nations. This is due to the high cost of cancer treatment and lack of availability of new treatments. Gynaecologi...
Read more